With the American consumer running out of breath amid an economic slowdown in the second half of 2025, Stifel sees a selloff ...

Stifel’s Barry Bannister says stocks are due for a big drop and thinks investors should play defense with staples and ...

Valneva confirmed its outlook for 2025, including expectations for total revenue between 180 million and 190 million euros. Total revenue last year was approximately 170 million euros. With Pfizer, ...

IDEX’s second quarter results were marked by better-than-expected revenue and non-GAAP profitability, but the market ...

Eden Kruger, a 15-year-old from Hopewell Junction, is among the top emerging U.S. moguls skiers. With stellar performances ...

U.S. stocks edged back from their record heights in Wall Street’s final moves before an upcoming update on inflation.

The embattled Richmond businessman was largely defeated last month in his attempt to overturn his 2021 criminal fraud ...

U.S. stocks edged back from their record heights on Monday in Wall Street's final moves before an upcoming update on ...

Stifel Nicolaus analyst Ian Gillies maintained a Buy rating on ADENTRA today and set a price target of C$44.00. The company’s shares closed last Wednesday at $21.78. Elevate You ...

Discover key insights from Xenon Pharmaceuticals' Q2 2025 earnings call, including milestones in epilepsy, depression trials, and a strong cash ...

U.S. stocks edged back from their record heights on Monday in Wall Street’s final moves before an upcoming update on inflation.